Table 3. Comparison Of The Clinical Parametres In Survivors And Patients Who Died.
| Variable | Survivors (n 5 27) | Death (n 5 55) | p-value |
| Age (years) | 54.3 ± 18.3 | 65.6 ± 10.7 | 0.02 |
| Male (n %) | 16 (59.3) | 39 (70.9) | 0.12 |
| Literate (n %) | 17 (63.0) | 33 (60.0) | 0.87 |
| NYHA class III | 21 (77.8) | 36 (65.0) | 0.34 |
| IV | 6 (22.2) | 19 (34.5) | 0.16 |
| BMI (kg/m2) | 24.8 ± 6.3 | 27.2 ± 3.1 | 0.56 |
| SBP (mmHg) | 128.4 ± 18.6 | 142.6 ± 14.8 | 0.04 |
| DBP (mmHg) | 80.3 ± 18.5 | 85.5 ± 16.3 | 0.63 |
| PCV (%) | 33.8 ± 8.2 | 27.0 ± 1.4 | 0.30 |
| Serum urea (mg %) | 52.0 ± 10.8 | 53.4 ± 10.4 | 0.76 |
| Serum creatinine (mg %) | 0.9 ± 0.4 | 1.5 ± 0.7 | 0.06 |
| Serum Na (mEq/l) | 132.6 ± 6.6 | 124.8 ± 3.2 | 0.08 |
| eGFR (ml/min) | 75.5 ± 15.3 | 45.6 ± 18.6 | 0.009 |
| AF (n %) | 3 (11.1) | 14 (25.5) | 0.02 |
| LVEF (%) | 23.6 ± 6.2 | 18.8 ± 8.1 | 0.42 |
| Congestion score > 3 (n %) | 12 (44.4) | 33 (60.0) | 0.007 |
| Perfusion score > 3 (n %) | 11 (40.7) | 27 (49.1) | 0.04 |